Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. financial statements

Cullinan Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 219.88M10-K
Cash and equivalentsUSD 88.33M10-Q
Total debtUSD 2.68MEODHD

Cullinan Therapeutics, Inc. financials on 6ix · Cullinan Therapeutics, Inc. on 6ix